CTNNB1 and hepatocellular carcinoma: For example, 14% of HCC patients were with CTNNB1 mutations and most were missense mutations, however, the composition of TP53 mutations among the 14% mutated HCC patients were more diverse, in frame and frame shift mutations also contributed heavily in addition to missense mutation (Figure 1F).